These findings have important practical ramifications, because as long as there are some significant number residual beta cells in recent onset T1D, or even with islet and pancreas transplantation, reduction of glucose levels with treatment will lead to improved endogenous insulin secretion. The gene discussed is INS; the disease is type 1 diabetes mellitus.